ArticleOpen forum infectious diseases2026
Correction to: Optimizing the Use of Cabotegravir Plus Rilpivirine Long-acting Therapy in HIV Care: Evidence, Implementation, and Unanswered Questions.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.